Rabey JM - Search Results

1

Effect of quetiapine in psychotic Parkinson's disease patients: a double-blind labeled study of 3 months' duration.

Rabey JM, Prokhorov T, Miniovitz A, Dobronevsky E, Klein C. Rabey JM, et al. Mov Disord. 2007 Feb 15;22(3):313-8. doi: 10.1002/mds.21116. Mov Disord. 2007. PMID: 17034006 Clinical Trial.

2

Long-term follow-up (24 months) of quetiapine treatment in drug-induced Parkinson disease psychosis.

Klein C, Prokhorov T, Miniovich A, Dobronevsky E, Rabey JM. Klein C, et al. Among authors: rabey jm. Clin Neuropharmacol. 2006 Jul-Aug;29(4):215-9. doi: 10.1097/01.WNF.0000228176.98582.93. Clin Neuropharmacol. 2006. PMID: 16855423 Clinical Trial.

3

Clozapine in Parkinson's disease psychosis: 5-year follow-up review.

Klein C, Gordon J, Pollak L, Rabey JM. Klein C, et al. Among authors: rabey jm. Clin Neuropharmacol. 2003 Jan-Feb;26(1):8-11. doi: 10.1097/00002826-200301000-00003. Clin Neuropharmacol. 2003. PMID: 12567158

4

Excessive daytime sleepiness in patients with Parkinson's disease: a polysomnography study.

Shpirer I, Miniovitz A, Klein C, Goldstein R, Prokhorov T, Theitler J, Pollak L, Rabey JM. Shpirer I, et al. Among authors: rabey jm. Mov Disord. 2006 Sep;21(9):1432-8. doi: 10.1002/mds.21002. Mov Disord. 2006. PMID: 16773617

5

The effect of quetiapine in psychotic Parkinsonian patients with and without dementia. An open-labeled study utilizing a structured interview.

Prohorov T, Klein C, Miniovitz A, Dobronevsky E, Rabey JM. Prohorov T, et al. Among authors: rabey jm. J Neurol. 2006 Feb;253(2):171-5. doi: 10.1007/s00415-005-0943-4. Epub 2005 Aug 17. J Neurol. 2006. PMID: 16096815 Clinical Trial.

6

Rapid improvement of tardive dyskinesia with tetrabenazine, clonazepam and clozapine combined: a naturalistic long-term follow-up study.

Kimiagar I, Dobronevsky E, Prokhorov T, Miniovitz A, Rabey JM. Kimiagar I, et al. Among authors: rabey jm. J Neurol. 2012 Apr;259(4):660-4. doi: 10.1007/s00415-011-6235-2. Epub 2011 Nov 9. J Neurol. 2012. PMID: 22068977

7

Association between amantadine and the onset of dementia in Parkinson's disease.

Inzelberg R, Bonuccelli U, Schechtman E, Miniowich A, Strugatsky R, Ceravolo R, Logi C, Rossi C, Klein C, Rabey JM. Inzelberg R, et al. Among authors: rabey jm. Mov Disord. 2006 Sep;21(9):1375-9. doi: 10.1002/mds.20968. Mov Disord. 2006. PMID: 16705684

8

Comparison of the Unified Parkinson's Disease Rating Scale and the Short Parkinson's Evaluation Scale in patients with Parkinson's disease after levodopa loading.

Rabey JM, Klein C, Molochnikov A, Van Hilten B, Krauss P, Bonuccelli U. Rabey JM, et al. Clin Neuropharmacol. 2002 Mar-Apr;25(2):83-8. doi: 10.1097/00002826-200203000-00005. Clin Neuropharmacol. 2002. PMID: 11981234

9

H reflex threshold in Parkinson's disease patients for different stimulus duration.

Kushnir M, Klein C, Pollak L, Rabey JM. Kushnir M, et al. Among authors: rabey jm. Parkinsonism Relat Disord. 2002 Dec;9(2):85-7. doi: 10.1016/s1353-8020(02)00033-0. Parkinsonism Relat Disord. 2002. PMID: 12473397

10

Phenotypic presentation of frontotemporal dementia with Parkinsonism-chromosome 17 type P301S in a patient of Jewish-Algerian origin.

Werber E, Klein C, Grünfeld J, Rabey JM. Werber E, et al. Among authors: rabey jm. Mov Disord. 2003 May;18(5):595-8. doi: 10.1002/mds.10401. Mov Disord. 2003. PMID: 12722177

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

148 results

Search Page

Filters